Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yukie Mitsuda

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Biotechnology and Bioengineering|October 24, 2003
Catalytic features of monoclonal antibody i41SL1-2 subunitsEmi Hifumi, Hiroyuki Kondo, Yukie Mitsuda, et al.
Immunology Letters|April 23, 2003
Endopeptidase character of monoclonal antibody i41-7 subunitsKenji Hatiuchi, Emi Hifumi, Yukie Mitsuda, et al.
Journal of Immunological Methods|October 16, 2002
Targeted destruction of the HIV-1 coat protein gp41 by a catalytic antibody light chainEmi Hifumi, Yukie Mitsuda, Kyoko Ohara, et al.
Immunology Letters|December 9, 2004
Investigation of active form of catalytic antibody light chain 41S-2-LYukie Mitsuda, Kumi Tsuruhata, Emi Hifumi, et al.
Biotechnology and Bioengineering|March 31, 2004
Catalytic antibody light chain capable of cleaving a chemokine receptor CCR-5 peptide with a high reaction rate constantYukie Mitsuda, Emi Hifumi, Kumi Tsuruhata, et al.
The Journal of Biological Chemistry|September 6, 2012
Constant domain-regulated antibody catalysisGopal Sapparapu, Stephanie Planque, Yukie Mitsuda, et al.
Journal of Biotechnology|April 5, 2014
Metal-dependent amyloid β-degrading catalytic antibody constructYasuhiro Nishiyama, Hiroaki Taguchi, Mariko Hara, et al.
Molecular Biotechnology|October 5, 2007
Naturally occurring catalytic antibodies: evidence for preferred development of the catalytic function in IgA class antibodiesYukie Mitsuda, Stephanie Planque, Mariko Hara, et al.
The Journal of Biological Chemistry|August 31, 2007
Towards covalent vaccination: improved polyclonal HIV neutralizing antibody response induced by an electrophilic gp120 V3 peptide analogYasuhiro Nishiyama, Yukie Mitsuda, Hiroaki Taguchi, et al.
The Journal of Biological Chemistry|December 17, 2003
Toward selective covalent inactivation of pathogenic antibodies: a phosphate diester analog of vasoactive intestinal peptide that inactivates catalytic autoantibodiesYasuhiro Nishiyama, Gita Bhatia, Yogesh Bangale, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Biotechnology and Bioengineering|October 24, 2003
Catalytic features of monoclonal antibody i41SL1-2 subunitsEmi Hifumi, Hiroyuki Kondo, Yukie Mitsuda, et al.
Immunology Letters|April 23, 2003
Endopeptidase character of monoclonal antibody i41-7 subunitsKenji Hatiuchi, Emi Hifumi, Yukie Mitsuda, et al.
Journal of Immunological Methods|October 16, 2002
Targeted destruction of the HIV-1 coat protein gp41 by a catalytic antibody light chainEmi Hifumi, Yukie Mitsuda, Kyoko Ohara, et al.
Immunology Letters|December 9, 2004
Investigation of active form of catalytic antibody light chain 41S-2-LYukie Mitsuda, Kumi Tsuruhata, Emi Hifumi, et al.
Biotechnology and Bioengineering|March 31, 2004
Catalytic antibody light chain capable of cleaving a chemokine receptor CCR-5 peptide with a high reaction rate constantYukie Mitsuda, Emi Hifumi, Kumi Tsuruhata, et al.
The Journal of Biological Chemistry|September 6, 2012
Constant domain-regulated antibody catalysisGopal Sapparapu, Stephanie Planque, Yukie Mitsuda, et al.
Journal of Biotechnology|April 5, 2014
Metal-dependent amyloid β-degrading catalytic antibody constructYasuhiro Nishiyama, Hiroaki Taguchi, Mariko Hara, et al.
Molecular Biotechnology|October 5, 2007
Naturally occurring catalytic antibodies: evidence for preferred development of the catalytic function in IgA class antibodiesYukie Mitsuda, Stephanie Planque, Mariko Hara, et al.
The Journal of Biological Chemistry|August 31, 2007
Towards covalent vaccination: improved polyclonal HIV neutralizing antibody response induced by an electrophilic gp120 V3 peptide analogYasuhiro Nishiyama, Yukie Mitsuda, Hiroaki Taguchi, et al.
The Journal of Biological Chemistry|December 17, 2003
Toward selective covalent inactivation of pathogenic antibodies: a phosphate diester analog of vasoactive intestinal peptide that inactivates catalytic autoantibodiesYasuhiro Nishiyama, Gita Bhatia, Yogesh Bangale, et al.
Pageof 2